Search

everythinglearnresearchcommunity

for

Search:↓

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Targeting ornithine decarboxylase can help prevent skin cancer.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Loss of TET2 increases the risk of skin and oral cancer.

Zebrafish are useful for studying and developing treatments for human skin diseases.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

ODC overexpression in hair cells increases tumor growth by reducing Notch signaling.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.